Latesha Richards

Bill Bernbach said “observe the obvious” and there have been a lot of obvious things in need of our observation these last couple of months.

Can software really treat disease? Until recently, many in healthcare would have viewed this question as absurd. After all, most disease is fundamentally biological or physiological. How can software help? For over a decade, a growing number of companies have sought to answer that question by developing a new class of treatments called digital therapeutics (DTx). are software or software-based solutions intended to treat or manage a disease or medical condition and backed by clinical evidence.

Pharma marketers, publishers, and agencies agree: Content is key to standing out in an increasingly competitive marketplace. Recognizing the significance of content, brands have historically invested in resources on their owned and operated sites, social programs, and publisher sponsorships. Yet content marketers are at a loss when it comes to calculating the holistic impact of their investment.